Practical issues in counseling healthy women about their breast cancer risk and use of tamoxifen citrate

Archives of Internal Medicine

Volumn 160, Issue 20, 2000, Pages 3034-3042

  Smedira, H J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ASTROGLIDE; BELLADONNA ALKALOID; BELLERGAL S; BIOFLAVONOID; CLONIDINE; ERGOTAMINE TARTRATE; ESTRADIOL; LUBRICATING AGENT; LUBRIN; PAROXETINE; PERIDIN C; PHENOBARBITAL; REPLENS; TAMOXIFEN CITRATE; VAGISIL; WARFARIN;

AGE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG POTENTIATION; EARLY DIAGNOSIS; ENDOMETRIUM CARCINOMA; FOLLOW UP; HUMAN; ILLNESS BEHAVIOR; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK MANAGEMENT; TREATMENT INDICATION;

EID: 0034645436     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.20.3034     Document Type: Review

References (40)

1. Deaths: Final data for 1997
2. What do women care about?
3. Adherence and psychological adjustment among women at high risk for breast cancer
4. Young women at increased risk for breast cancer: Perceived risk, psychological well-being, and surveillance behavior
5. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age
6. Putting the risk of breast cancer in perspective
7. Psychological distress and surveillance behaviors of women with a family history of breast cancer
8. Mammography adherence and psychological distress among women at risk for breast cancer
9. Attitudes about genetic testing for breast-ovarian cancer susceptibility
10. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
11. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer
12. The lifetime risk of developing breast cancer
13. Breast cancer (1)
14. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
15. Validation of the Gail et al model for predicting individual breast cancer risk
16. Validation of a breast cancer risk assessment model in women with a positive family history
17. Validation studies for models projecting the risk of invasive and total breast cancer incidence
18. Family history, age, and risk of breast cancer: Prospective data from the Nurses' Health Study
19. Genetic study of breast cancer: Identification of a high risk group
20. Risk of familial breast cancer
21. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
22. Breast and ovarian cancer incidence in BRCA1-mutation carriers
23. Population-based study of risk of breast cancer in carriers of BRCA2 mutation
24. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study
25. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three US population-based case-control studies of ovarian cancer
26. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
27. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
28. Tamoxifen for early breast cancer: An overview of the randomised trials
29. Risk factors for breast cancer in women with proliferative breast disease
30. Endometrial carcinoma and tamoxifen: Clearing up a controversy
31. Tamoxifen therapy for breast cancer an d endometrial cancer risk
32. Tamoxifen and endometrial cancer
33. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen
34. What you don't know can hurt you: Adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing
35. Patient-identified needs for hormone replacement therapy counseling: A qualitative study
36. Psychological counseling strategies for women at risk of breast cancer
37. Effects of individualized breast cancer risk counseling: A randomized trial